US FDA approves Astellas’ combination therapy for bladder cancer, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

The U.S. Food and Drug Administration on Friday approved Astellas Pharma’s Padcev in combination with Merck’s Keytruda for a type of bladder cancer., The U.S. Food and Drug Administration on Friday approved Astellas Pharma’s Padcev in combination with Merck’s Keytruda for a type of bladder cancer., , Read More